Donate and DOUBLE your Impact to End Breast Cancer

19

March 4, 2025

NBCC begins its collaboration with Translational Research In Oncology and Novartis on the NATALEE clinical trial of CDK4/6 inhibitors in early high-risk HR+/HER2- breast cancer.